Gut-On-A-Chip: Assessing Drug-Induced Gut Toxicity In Vitro

The gastrointestinal (GI) tract is one of the most common organs affected by adverse drug reactions. While it is essential to assess GI toxicity early in drug development, traditional toxicity assays using model cell lines do not accurately reflect the human gut. Stem cell-based technologies that recreate the human intestine enable researchers to better evaluate drug-induced GI toxicity during candidate drug screening. In this webinar, our experts will discuss the latest advances of GI toxicity assessment empowered by stem cell and organ-on-a-chip technology.